These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Morrow JD, Minton TA, Badr KF, Roberts LJ. Biochim Biophys Acta; 1994 Jan 03; 1210(2):244-8. PubMed ID: 8280777 [Abstract] [Full Text] [Related]
3. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. Schweer H, Watzer B, Seyberth HW, Nüsing RM. J Mass Spectrom; 1997 Dec 03; 32(12):1362-70. PubMed ID: 9423285 [Abstract] [Full Text] [Related]
4. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C. Arterioscler Thromb Vasc Biol; 1997 Nov 03; 17(11):3230-5. PubMed ID: 9409316 [Abstract] [Full Text] [Related]
6. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man. Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C. Br J Pharmacol; 1997 Aug 28; 121(8):1770-4. PubMed ID: 9283716 [Abstract] [Full Text] [Related]
7. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggård EE. J Chromatogr B Biomed Appl; 1995 May 19; 667(2):199-208. PubMed ID: 7663692 [Abstract] [Full Text] [Related]
8. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Kromer BM, Tippins JR. Br J Pharmacol; 1996 Nov 19; 119(6):1276-80. PubMed ID: 8937734 [Abstract] [Full Text] [Related]
9. Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. Fukunaga M, Yura T, Badr KF. J Cardiovasc Pharmacol; 1995 Nov 19; 26 Suppl 3():S51-2. PubMed ID: 8587462 [Abstract] [Full Text] [Related]
16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K, Halushka PV, Yan YT, Wong PY. J Pharmacol Exp Ther; 1994 Sep 15; 270(3):1192-6. PubMed ID: 7932171 [Abstract] [Full Text] [Related]
17. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Kawikova I, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, Belvisi MG. Am J Respir Crit Care Med; 1996 Feb 15; 153(2):590-6. PubMed ID: 8564103 [Abstract] [Full Text] [Related]
18. Effects of 8-epi-prostaglandin F2 alpha and U46,619 on pulmonary hemodynamics in piglets. Truog WE, Norberg M, Thibeault DW. Biol Neonate; 1997 Feb 15; 71(5):306-16. PubMed ID: 9167852 [Abstract] [Full Text] [Related]
19. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. Wang Z, Ciabattoni G, Créminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. J Pharmacol Exp Ther; 1995 Oct 15; 275(1):94-100. PubMed ID: 7562601 [Abstract] [Full Text] [Related]